Breast (Mar 2023)

P166 Budget impact of MammaPrint® in Patients with primary hormone receptor-positive, HER2-negative and non-metastatic early-stage breast cancer in France

  • D. Zarca,
  • M. Delomenie,
  • P. Pujol,
  • J. Klinkhamer,
  • P.G. Cusumano

Journal volume & issue
Vol. 68
pp. S79 – S80

Abstract

Read online

No abstracts available.